Search Results
133 Results for 'Drug Discovery & Development'
PAGE 2 OF 6
Technology
Cell-Based Assay for Identifying Inhibitors of Viral Translational Recoding
Viruses maximize their genetic potential through several mechanisms including expressing multiple protein products from a single mRNA template. A crucial mechanism is conserved by both retroviruses, i...
Learn More
Learn More
Nathan Sherer, Bayleigh Benner | P200340US01
Technology
PLASMID ENCODING INFECTIOUS RHINOVIRUS-C GENOTYPE C45
UW-Madison researchers have cloned, sequenced and characterized the genome from an isolate of the RV-C45 genotype, and they’ve provided the cDNA for a high titer HRV-C (C45-2A-D41K), as well as ...
Learn More
Learn More
Ann Palmenberg | P210398US01
Technology
RPE CELL LINES WITH PLK4 CONDITIONAL KNOCKOUT AND ANALOG SENSITIVE MUTATION
UW-Madison researchers have developed two cell lines derived from RPE-1 cells (which were obtained from ATCC), an immortalized, non-transformed human epithelial cell line. “PLK4 WTflox/Delta&rdq...
Learn More
Learn More
Mark Burkard, Ryan Denu | P210364US01
Technology
CHO Cell Line Expressing HERG-1 Potassium Channels
HERG-1 (human ether-a-go-go-related gene) potassium channels mediate repolarization of cardiac action potentials. Loss of function mutations in hERG-1 can result in long QT syndrome, an inherited diso...
Learn More
Learn More
Gail Robertson, Barry Ganetzky, Jeffrey Warmke, Matthew Trudeau, Samuel Breit, Terence Campbell, Bruce Walker, Stella Valenzuela | P00082US
Technology
Fluorescent-Tagged Moraxella Catarrhalis For Cell Culture Experiments
The present invention is a fluorescence-based cell assay for studying the replication of Moraxella catarrhalis. UW-Madison researchers developed a bacterial strain that fluoresces red by producing the...
Learn More
Learn More
Cameron Currie, Reed Stubbendieck | P210244US01
Technology
Plasmids And Cell Lines Expressing The DMPK 3'UTR
The UW Madison researchers' invention is a set of plasmid constructs and cell lines developed to investigate the effects of RNA toxicity in myotonic dystrophy. The inventor created two constructs link...
Learn More
Learn More
Mani Mahadevan, Jeffrey Amack | P210221US01
Technology
Method Of In Vitro Differentiation Of Neural Stem Cells, Motor Neurons And Dopamine Neurons From Pri
A method of differentiating embryonic stem cells into ventral spinal progenitor cells is disclosed. In one embodiment, the invention comprises culturing a population of cells comprising a majority of ...
Learn More
Learn More
Su-Chun Zhang, Xue-jun Li | P07445US
Technology
GLYCORANDOMIZATION AND PRODUCTION OF NOVEL VANCOMYCIN ANALOGS
The present invention provides combinatorial methods for rapidly generating a diverse library of glycorandomized structures, comprising incubating one or more aglycons and a pool of NDP-sugars in the ...
Learn More
Learn More
Jon Thorson | P04116US
Technology
Neoglycorandomization And Digitoxin Analogs
The present invention provides methods of producing libraries of compounds with enhanced desirable properties and diminished side effects as well as the compounds produced by the methods. In preferred...
Learn More
Learn More
Joseph Langenhan | P08057US
Technology
Enhanced Neoglycosides Through Neoglycosylation And Methods Of Use Thereof
Using neoglycosylation, the impact of differential glycosylation upon the divergent anticancer and anti-HIV properties of the triterpenoid betulinic acid (BA) was examined. Each member from a library ...
Learn More
Learn More
Jon Thorson, Randal Goff | P07498US02
Technology
Method For Evaluating The Solubility Of A Crystalline Substance In A Polymer
A viable strategy to enhance the bioavailability of poorly soluble drugs is to use amorphous solids in place of the more commonly used crystalline solids in pharmaceutical formulations. However, amorp...
Learn More
Learn More
Lian Yu, Geoff GZ Zhang, Jing Tao, Ye Sun, Markus Maegerlein | P140053US05
Technology
Reversible Natural Product Glycosyltransferase-catalyzed Reactions, Compounds And Related Methods
The present invention relates to methods of use of glycosyltransferases and related compounds. The invention exploits the reversibility of glycosyltransferases to generate new sugars, unnatural biomol...
Learn More
Learn More
Jon Thorson, Byron Griffith, Changsheng Zhang | P06427US
Technology
Topical Vasoconstrictor Preparations And Methods For Protecting Cells During Cancer Chemotherapy And
Vasoconstrictors are administered topically to provide protection against the adverse effects, e.g., alopecia, mucositis or dermatitis, induced by chemotherapy or radiotherapy. Appropriate dosages and...
Learn More
Learn More
William Fahl, Arnold Ruoho, Minesh Mehta | P05246US
Technology
Compositions,m Ethods And Devices For Preparing Less Painful Botulinum Toxin Formulations
Devices, methods and kits are disclosed for preparing and administering less-painful formulations of Botulinum toxin. The devices, methods and kits of the present invention are comprised of or use an ...
Learn More
Learn More
Gary Borodic, Martin Acquadro | P05406US
Technology
Method Of Preparing Botulinum Neurotoxin Type A Light Chain
The present invention provides a preparation of botulinum toxin light chain type A or E, wherein the preparation is both catalytically active and soluble. Preferably, the preparation consists essentia...
Learn More
Learn More
Eric Johnson, Marite Bradshaw, Joseph Barbieri, Michael Baldwin | P04467US
Technology
Synthesis Of Small Molecule Histone Deacetylase 6 Degraders, Compounds Formed Thereby, And Pharmaceutical Compositions Containing Them
Histone deacetylase (“HDAC”)-selective inhibitors covalently bonded to a linker covalently bonded to an E3 ubiquitin ligase ligand, and salts thereof; pharmaceutical compositions containing them; ...
Learn More
Learn More
Weiping Tang, Ka Yang, Hao Wu, Zhongrui Zhang | P180321US05
Technology
Methods And Culture Substrates For Controlled Induction Of Biomimetic Neural Tissues Comprising Singular Rosette Structures
Described herein are methods, compositions, and kits for directed differentiation of human pluripotent stem cells, neuromesodermal progenitors, and neural stem cells into biomimetic neural tissues com...
Learn More
Learn More
Randolph Ashton, Gavin Knight | P170180US02
Technology
Isogenic Blood-Brain Barrier Model
A method of creating an isogenic multicellular blood-brain barrier model from iPSCs is disclosed.
Learn More
Learn More
Eric Shusta, Scott Canfield, Clive Svendsen, Gad Vatine, Sean Palecek | P160286US02
Technology
Photochemical Methods Of Making Cyclobutane Boronates And Related Compounds
The present technology relates generally cyclobutane boronates, including methods of preparation by exposing a mixture of a compound of Formula I in a solvent [Image Omitted] and a catalytic amount o...
Learn More
Learn More
Tehshik Yoon, Spencer Scholz, Rowan Littlefield, Niecia Flikweert | P170290US02
Technology
Using Liquid Crystal To Detect Endotoxin In The Presence Of One Or More Potential Masking Agents
Devices and methods for using changes in the configuration of micrometer sized dispersed liquid crystal domains to detect or quantify analytes in a test sample, including endotoxin lipopolysaccharide ...
Learn More
Learn More
Nicholas Abbott, Abhijit Dan | P160072US02
Technology
Engineered Prephenate Dehydrogenases And Arogenate Dehydrogenases And Methods Of Using The Same
The invention generally relates to engineered prephenate dehydrogenases and arogenate dehydrogenases and methods of using the same. More specifically, the invention relates in part to compositions inc...
Learn More
Learn More
Hiroshi Maeda, Craig Schenck | P170121US02
Technology
Arogenate Dehydrogenase Polynucleotides, Polypeptides And Methods Of Using The Same
The invention generally relates to arogenate dehydrogenase polynucleotides and methods of using the same. More specifically, the invention relates in part to compositions including arogenate dehydroge...
Learn More
Learn More
Hiroshi Maeda, Samuel Lopez Nieves, Marcos Vinicius Viana de Oliveira | P170120US02
Technology
Coated Egg Yolk Cores, Methods Of Making And Methods Of Use Thereof
A method of making coated avian egg yolk cores includes providing dried avian egg yolk cores having a diameter of 100 to 1500 micrometers, applying avian egg albumen to the dried avian egg yolk cores ...
Learn More
Learn More
Mark Cook, Jordan Sand | P170345US01
Technology
Human Pluripotent Stem Cell-Derived Brain Organoids For Cancer Modeling And Drug Screening
The present invention relates to substantially planar vascularized brain cancer organoid and methods of using such vascularized brain cancer organoids in anti-cancer drug discovery screen. In particul...
Learn More
Learn More
William Murphy, Elizabeth Aisenbrey, Elizabeth Torr, Victoria Harms, Gaurav Kaushik | P190185US02
Technology
Expansion And Maintenance Of Adult Primary Human Hepatocytes In Culture
Methods for derivation, culture, and maturation of small hepatic progenitor cells are described.
Learn More
Learn More
James Thomson, Srikumar Sengupta | P180325US03